Just the aged care sector alone with FDA approval will make PCK profitable. And the fact that it is based on ARR, that means once the profit line is reached, it will only grow and grow with potential big spurts from infant apps downloads.
A monster in the making. Yes, it took longer than expected but with FDA, it will be very hard for anyone else to monster themselves into our market. In fact, PCK could well become a take over target once FDA drops. Very juicy in its infancy before its infant apps start to grow
PCK Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
